Personally I’ve never heard of shares being consolidated
to stop shorters from shorting....
Sounds great a one for ten consolidation. Then there will
only be about 167 million shares around. Next the board says
gee we have less than 200 million shares by time Mithra gets
their second helping. Think we could issue some more shares?
Great idea let’s have a CR to reduce some debt or worse
another ill thought out purchase. That way all
those retail holders will get completely diluted because they are
skint from losing millions of combined dollars from a business
that’s been heading south.
Here’s a different novel idea. Get some drug approvals and start
making some sensible decisions that make money rather than
losing it all the time. It’s not rocket science it’s about running a
lean business that makes robust ROE and ROA. Use profit to
pay down debt and if responsible and prudent then pay a divvy
or consider a buyback when prices are low not high. Shorts won’t
leave of their own volition. Why should they? They won’t go
voluntarily you have to give them a solid boot up the kyber
pass with profits and show the market that they are worth 75
cents not 35 cents. Shorts are exposing Myx for their obvious flaws,
and are calling the company’s bluff. Until management takes some
genuine lessons they won’t get the shorts monkey off their backs.
If Mayne had some uplifting news they’d most likely get it out to
the market quick smart so to my mind they have no current ace
up their sleeve. It’s as simple as that. Make decent profits and the
share price will correct upwards and the shorts will pick on some
other company that is over priced. SR created the problem and if
he can’t fix it then let someone else in who can!
- Forums
- ASX - By Stock
- MYX
- share consolidation
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

share consolidation, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
2 | 3150 | 5.040 |
1 | 600 | 5.030 |
3 | 3000 | 5.000 |
1 | 10000 | 4.980 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.180 | 2396 | 2 |
5.190 | 5000 | 1 |
5.200 | 157 | 1 |
5.210 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online